|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's range||160.16 - 168.51|
|52-week range||113.36 - 249.73|
|Beta (5Y monthly)||1.49|
|PE ratio (TTM)||198.95|
|Earnings date||08 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||188.71|
ShockWave Medical (NASDAQ:SWAV) has had a rough month with its share price down 35%. However, a closer look at its...
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and expansion in gross margin.
Joining me today from Shockwave Medical are Doug Godshall, president and chief executive officer; Isaac Zacharias, chief commercial officer; and Dan Puckett, chief financial officer. By comparison, less than 10% of U.S. cases is used intravascular imaging.